Top Stocks in Focus: TCS, Akzo Nobel, Emcure Pharma, Adani Ent, and Tata Technologies Among Companies to Watch
  • 593 views
  • 2 min read
  • 1 likes

Indian stock markets closed lower on Wednesday, July 9, 2025, amid selling pressure in IT and metal stocks. The Sensex settled at 83,536.08, a decline of 0.21%, while the Nifty 50 closed at 25,476.10, down by 0.18%. Tracking mixed cues from global markets, Sensex and Nifty 50 are expected to have a sluggish start on Thursday. Here's a look at some of the stocks that are expected to be in focus:

TCS

Tata Consultancy Services (TCS) is set to announce its Q1FY26 results on July 10, 2025. Brokerages estimate a modest 1-3% year-on-year net profit growth, projecting profits between Rs 12,040 crore and Rs 12,416 crore. Revenue is expected to rise by 2.7-3.8%, reaching between Rs 62,613 crore and Rs 64,993 crore. However, analysts anticipate a sequential dip in both revenue and profit, weighed down by the ramp-down of key deals. TCS is also implementing a stricter bench policy, mandating a minimum of 225 days of billing per year for employees. The maximum bench time is now limited to 35 days annually, and violations of this policy will impact compensation and career growth.

Akzo Nobel

Akzo Nobel is in the news following the announcement that JSW Paints will acquire a 74.76% stake in Akzo Nobel India for Rs 9,400 crore. Shares of Akzo Nobel India surged after this announcement. The deal is subject to regulatory approvals and an open offer. In other news, Asian Paints sold a 4.42% equity stake in Akzo Nobel for Rs 734 crore, while ICICI Prudential MF bought 7 lakh shares for Rs 256 crore. Recently, Akzo Nobel announced Fredrik Westin as Chief Financial Officer from January 1, 2026.

Emcure Pharma

Emcure Pharmaceuticals' oncology manufacturing facility in Ahmedabad passed a US FDA inspection without any observations. Emcure will acquire the remaining 20.42% stake in Zuventus Healthcare Ltd for Rs 724.9 crore, making Zuventus a wholly-owned subsidiary. Bain Capital is expected to offload a 2.4% stake in Emcure Pharmaceuticals through a block deal. Emcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit, driven by strong domestic and international growth.

Adani Enterprises

Adani Enterprises' Rs 1,000 crore NCD issue was fully subscribed within three hours of opening on Wednesday. The bond issue received bids worth over Rs 1,400 crore by 15:30 hours, with participation from non-institutional investors, including retail investors and HNIs. AdaniConneX, a joint venture of Adani Enterprises, has completed the acquisition of Granthik Realtors Private Ltd (GRPL) for Rs 85.99 crore to strengthen its infrastructure capabilities. Adani Enterprises is dealing with ongoing SEC scrutiny.

Tata Technologies

Tata Technologies has been selected as a strategic supplier by Volvo Cars. JM Financial maintains a "buy" call on Tata Technologies with a target price of Rs 850, citing encouraging underlying trends. Tata Technologies shares experienced a dip following a block deal where TPG sold shares worth approximately Rs 634 crore. Decisions to invest in the US are likely to be delayed due to lack of clarity over tariff policy.


Written By
Rohan Reddy is an emerging journalist with a strong commitment to nuanced reporting, propelled by his passion for sports. He possesses a foundational understanding of journalistic principles and is keen to develop his skills in a dynamic media environment. Rohan is eager to explore compelling human interest stories and complex societal issues, aiming to contribute impactful and well-researched content to the field of journalism, always finding inspiration in the competitive spirit of sports.
Advertisement

Latest Post


Advertisement
Advertisement
About   •   Terms   •   Privacy
© 2025 DailyDigest360